ProfileGDS4718 / 40562_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 98% 98% 93% 97% 97% 93% 88% 98% 97% 97% 97% 97% 93% 89% 90% 93% 96% 89% 86% 90% 96% 96% 97% 97% 96% 93% 97% 89% 97% 91% 90% 85% 98% 97% 83% 87% 94% 97% 98% 88% 98% 86% 91% 85% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.362798
GSM549102patient 115, normal, homogenized [OPG study]11.279898
GSM549104patient 119, normal, homogenized [OPG study]9.764593
GSM549108patient 138, normal, homogenized [OPG study]10.99797
GSM549119patient 077, normal, homogenized [OPG study]10.939797
GSM549133patient 032, cancer, homogenized [OPG study]9.7837893
GSM549139patient 042, cancer, homogenized [OPG study]8.9049888
GSM549099patient 107, normal, homogenized [OPG study]11.256498
GSM549109patient 139, normal, homogenized [OPG study]11.044897
GSM549110patient 046, normal, homogenized [OPG study]11.271797
GSM549114patient 063, normal, homogenized [OPG study]10.997897
GSM549122patient 082, normal, homogenized [OPG study]11.164297
GSM549134patient 033, cancer, homogenized [OPG study]9.7570193
GSM549136patient 036, cancer, homogenized [OPG study]9.128589
GSM549140patient 044, cancer, homogenized [OPG study]9.2966990
GSM549111patient 047, normal, homogenized [OPG study]9.8239793
GSM549113patient 057, normal, homogenized [OPG study]10.670996
GSM549132patient 031, cancer, homogenized [OPG study]9.0781289
GSM549137patient 038, cancer, homogenized [OPG study]8.5337686
GSM549142patient 047, cancer, homogenized [OPG study]8.677990
GSM549100patient 110, normal, homogenized [OPG study]10.723396
GSM549107patient 135, normal, homogenized [OPG study]10.807996
GSM549115patient 068, normal, homogenized [OPG study]11.140697
GSM549116patient 072, normal, homogenized [OPG study]11.251497
GSM549120patient 078, normal, homogenized [OPG study]10.763796
GSM549131patient 030, cancer, homogenized [OPG study]9.807593
GSM549118patient 074, normal, homogenized [OPG study]10.935197
GSM549129patient 027, cancer, homogenized [OPG study]8.977289
GSM549123patient 088, normal, homogenized [OPG study]10.970797
GSM549124patient 006, cancer, homogenized [OPG study]9.2040391
GSM549126patient 015, cancer, homogenized [OPG study]9.1734290
GSM549128patient 025, cancer, homogenized [OPG study]8.5752985
GSM549103patient 117, normal, homogenized [OPG study]11.289798
GSM549117patient 073, normal, homogenized [OPG study]11.272797
GSM549138patient 041, cancer, homogenized [OPG study]8.2864983
GSM549141patient 045, cancer, homogenized [OPG study]8.8713187
GSM549130patient 028, cancer, homogenized [OPG study]9.7701294
GSM549101patient 111, normal, homogenized [OPG study]10.743597
GSM549105patient 128, normal, homogenized [OPG study]11.203898
GSM549106patient 134, normal, homogenized [OPG study]9.0695988
GSM549112patient 048, normal, homogenized [OPG study]11.623598
GSM549125patient 011, cancer, homogenized [OPG study]8.5551386
GSM549127patient 024, cancer, homogenized [OPG study]9.3540191
GSM549135patient 035, cancer, homogenized [OPG study]8.6223485